Author:
Zacny James P.,Wroblewski Kristen,Coalson Dennis W.
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders DSM-IV-TR. American Psychiatric Association, Washington, Text revision
2. Bader S, Dürk T, Becker G (2013) Methylnaltrexone for the treatment of opioid-induced constipation. Expert Review of Gastroenterology & Hepatology 7:13–26
3. Beattie DT, Cheruvu M, Mai N, O’Keefe M, Johnson-Rabidoux S, Peterson C et al (2007) The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08–0011 and methylnaltrexone. Naunyn-Schmiedeberg’s Archives of Pharmacology 375:205–220
4. Bigliardi PL, Stammer H, Jost G, Rufli T, Buchner S, Bigliardi-Qi M (2007) Treatment of pruritis with topically applied opiate receptor antagonist. Journal of the American Academy of Dermatology 56:979–988
5. Brown DR, Goldberg LI (1985) The use of quaternary narcotic antagonists in opiate research. Neuropharmacology 24:181–191
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献